We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stem Cell Spray Technology Could Help Treat Severe Wounds

By HospiMedica International staff writers
Posted on 05 Oct 2016
A quick-healing spray system uses a patient’s own stem cells as an alternative to conventional skin graft surgery, which can be painful, prone to complications, and slow-to-heal.

The CellMist System is an innovative investigational treatment for processing and spraying a patient’s own stem cells onto wounds for rapid healing. More...
The system is comprised of the CellMist Solution, a liquid suspension containing a patient’s own stem cells which are isolated from a small sample of their skin, using a patented extraction process. The second component of the system is the SkinGun device, which gently sprays the CellMist Solution on to a wound site for rapid healing. Once sprayed onto the wound site, the patient’s stem cells go to work, naturally and rapidly regenerating damaged skin.

Patented SkinGun technology results in 200-times more droplets formed than in conventional syringe deposition; for example, in an 8 cm diameter surface area, the SkinGun can deliver more than 20,000 evenly distributed droplets, versus only 91 droplets by conventional needle and syringe methods. The CellMist System is designed to replace traditional skin grafts, requiring only a postage stamp-sized sample of donor skin, which can be processed within 90 minutes of arriving in an emergency room. The CellMist System is under development by RenovaCare (New York, NY, USA).

“The prospect of spraying a patient’s own stem cells onto burns and wounds to create rapid, scar-free healing is a promising alternative to today’s painful and disfiguring skin grafting procedures,” said Thomas Bold, President and CEO of RenovaCare. “For patients, we are working towards natural, rapid healing where their new skin can look and function as well as it once did. For surgeons, it’s a relief to no longer have to remove vast sheets of healthy skin and surgically stitch it to wound sites.”

Most adult stem cells are lineage-restricted (multipotent) and are generally referred to by their tissue origin (mesenchymal stem cell, adipose-derived stem cell, endothelial stem cell, etc). They have been successfully used for many years to treat leukemia and related bone cancers through bone marrow transplants. Adult somatic stem cells can now be artificially grown and differentiated into specialized cell types with characteristics consistent with cells of various tissues.

Related Links:
RenovaCare



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.